The fund, under normal circumstances, invests at least 80% of its net assets (plus any borrowings for investment purposes) in financial instruments that are designed to provide, in the aggregate,200% inverse (opposite) exposure to the price performance of CRCL on a daily basis. The fund is non-diversified.
